Inhibikase Therapeutics (IKT) Cash & Current Investments (2020 - 2026)
Inhibikase Therapeutics (IKT) reported Cash & Current Investments of $159.02 million for Q2 2026, up 81.4% from $87.67 million a year earlier but down 6.7% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Inhibikase Therapeutics posted Cash & Current Investments of $178.76 million, up 83.3% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 66.5% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $97.54 million in FY2024 (+636.1%), $13.25 million in FY2023 (-42.5%), $23.05 million in FY2022 (-43.4%) and $40.75 million in FY2021 (+192.0%).
- Five-year quarterly Cash & Current Investments spans a low of $3.24 million in Q3 2024 and a high of $178.76 million in Q4 2025.
- Year over year, Cash & Current Investments has now increased in each of the last three quarters, with growth averaging 276.4% over the last six quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q1 2025 (growth of 855.8%); the low point was Q3 2024 (a decline of 80.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $170.37 million (Q1 2026), $178.76 million (Q4 2025) and $77.32 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Inhibikase Therapeutics | 349.14 Mn | -236.33 Mn | - | 159.02 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 159.02 Mn |
| Mar 31, 2026 | 170.37 Mn |
| Dec 31, 2025 | 178.76 Mn |
| Sep 30, 2025 | 77.32 Mn |
| Jun 30, 2025 | 87.67 Mn |
| Mar 31, 2025 | 93.18 Mn |
| Dec 31, 2024 | 97.54 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 7.94 Mn |
| Mar 31, 2024 | 9.75 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 16.83 Mn |
| Jun 30, 2023 | 20.94 Mn |
| Mar 31, 2023 | 25.72 Mn |
| Dec 31, 2022 | 23.05 Mn |
| Sep 30, 2022 | 26.53 Mn |
| Jun 30, 2022 | 32.21 Mn |
| Mar 31, 2022 | 36.61 Mn |
| Dec 31, 2021 | 40.75 Mn |
| Sep 30, 2021 | 44.85 Mn |
API Access
Inhibikase Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();